Dysregulation of peptidyl arginine deiminase 4 (PAD4) is involved in a variety of diseases
including rheumatoid arthritis (RA) and Alzheimer's disease (AD), and it has emerged as …

Background: Tripterygium glycosides have been used to treat systemic lupus erythematosus
(SLE) for a long time, showing the effects of immune regulation. We aimed to evaluate the …

Background: Systemic lupus erythematosus (SLE) significantly links to LN, a type of CKD
with high mortality despite modern Western treatments. About 70% of SLE patients develop …

Background: Total glucosides of paeony (TGP), extracted from the Chinese medicine
Paeonia lactiflora Pall., have been proven to be effective in various autoimmune diseases …

Objectives: To investigate the association between traditional Chinese medicine (TCM)
therapy and the risk of pneumonia in patients with systemic lupus erythematosus (SLE) …

Glucocorticoids (GC) are crucial in the treatment of rheumatoid arthritis (RA), but
discontinuing GC effectively in RA patients poses a significant challenge for …

Objective: To investigate the molecular mechanism and simulated validation of Zhi Bai Di
Huang Pill (ZBDHP) for the treatment of systemic lupus erythematosus (SLE) using network …

Complementary and integrative health approaches are used by patients worldwide to help
manage symptoms of acute and chronic disease. These approaches are outside the realm …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder affecting multiple
systems, characterized by the development of harmful autoantibodies and immune …

Cutaneous lupus erythematosus (CLE) is a group of autoimmune connective tissue
disorders that significantly impact quality of life. Current treatment approaches typically use …